JNJ Valuation

Johnson & Johnson

Add to Watchlist

Advanced Chart

168.170

-1.39(-0.820%)1D

Overview
Forecast
Valuation
Earnings

JNJ Relative Valuation

JNJ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, JNJ is overvalued; if below, it's undervalued.

Historical Valuation

Johnson & Johnson (JNJ) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.53 is considered Undervalued compared with the five-year average of 16.20. The fair price of Johnson & Johnson (JNJ) is between 217.25 to 238.63 according to relative valuation methord. Compared to the current price of 169.56 USD , Johnson & Johnson is Undervalued By 21.95%.

Relative Value

Fair Zone

217.25-238.63

Current Price：169.56

21.95%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

5.21

P/B

Median3y

5.45

Median5y

5.79

0.00

FCF Yield

Median3y

4.26

Median5y

4.43

Competitors Valuation Multiple

The average P/S ratio for JNJ's competitors is 4.63, providing a benchmark for relative valuation. Johnson & Johnson Corp (JNJ) exhibits a P/S ratio of 4.26, which is -7.92% above the industry average. Given its robust revenue growth of 5.77%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap